Clinica Chimica Acta

SJR Rank #5,463H-index: 182SJR: 0.935Best quartile: Q1APC: US$3,550
Journal website: aims, scope and author guidelines
Publisher

Elsevier B.V.

Country

Netherlands

Type

journal

SJR by Edition

2022202500.30.60.91.2

Subject Categories

  • Medicine (miscellaneous)Q1
  • BiochemistryQ2
  • Biochemistry (medical)Q2
  • Clinical BiochemistryQ2

Areas: Biochemistry, Genetics and Molecular Biology · Medicine

Most published research topics

Metabolism and Genetic DisordersDiabetes, Cardiovascular Risks, and LipoproteinsClinical Laboratory Practices and Quality ControlMetabolomics and Mass Spectrometry StudiesNeonatal Health and BiochemistryLiver Disease Diagnosis and TreatmentGlycosylation and Glycoproteins ResearchDiverse Scientific and Economic StudiesHuman auditory perception and evaluationEducational Robotics and Engineering

Source: OpenAlex

Publication Statistics

2025 Docs3-Year DocsCitable Docs03006009001200

Documents per Year

202220250150300450600

Detailed Information

ISSN

0009-8981, 1873-3492

SJR Best Quartile

Q1

Region

Western Europe

Citations per Document (2 years)

4.13

References per Document

61.51

Coverage

1956-2026

Scope

The Official Journal of the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) Clinica Chimica Acta is a high-quality journal which publishes original Research Communications in the field of clinical chemistry and laboratory medicine, defined as the diagnostic application of chemistry, biochemistry, immunochemistry, biochemical aspects of hematology, toxicology, and molecular biology to the study of human disease in body fluids and cells. The objective of the journal is to publish novel information leading to a better understanding of biological mechanisms of human diseases, their prevention, diagnosis, and patient management. Reports of an applied clinical character are also welcome. Papers concerned with normal metabolic processes or with constituents of normal cells or body fluids, such as reports of experimental or clinical studies in animals, are only considered when they are clearly and directly relevant to human disease. Evaluation of commercial products have a low priority for publication, unless they are novel or represent a technological breakthrough. Studies dealing with effects of drugs and natural products and studies dealing with the redox status in various diseases are not within the journal's scope. Development and evaluation of novel analytical methodologies where applicable to diagnostic clinical chemistry and laboratory medicine, including point-of-care testing, and topics on laboratory management and informatics will also be considered. Studies focused on emerging diagnostic technologies and (big) data analysis procedures including digitalization, mobile Health, and artificial Intelligence applied to Laboratory Medicine are also of interest.

Metrics from SCImago Journal Rank 2025. View on SCImago